Leading the Way in Life Science Technologies

GEN Exclusives

More »

New Products

Whether you are searching for a DNA purification kit or outfitting a cGMP facility, GEN’s comprehensive new product database is your first and only stop. Conveniently categorized and searchable, the database covers the latest innovations from industry-leading suppliers.

Sartorius Stedim Biotech

  • Page 1 of 1 (5 items) 1 

Small-Scale Crossflow Device

Sartorius Stedim Biotech

The Sartocon ® Slice 50 is a single-use crossflow ultrafilter device designed for use in biotechnological applications, especially for membrane screening and small-volume process development. This device is offered as an encapsulated and...

Automated Cell Culture System

Sartorius Stedim Biotech

The new SelecT Mk5 system has been redesigned to upgrade its flask handling and pipetting capabilities, and now comes with an integrated Vi-CELL ® Cell Viability Analyzer and a new Low Volume Reagent Dispensing module. The system can use...

Crossflow Filtration System

Sartorius Stedim Biotech

The Sartoflow ® Smart is a benchtop crossflow system for optimized ultra- and diafiltration applications. It can ideally be used in many downstream processes, such as purification of vaccines, monoclonal antibodies, and recombinant prote...

Microscale Bioreactor System

Sartorius Stedim Biotech

The ambr ® 15 fermentation system is an automated microbioreactor platform designed to enhance microbial strain screening with advanced capabilities supporting fed-batch microbial cultures. The system comprises 24 single-use stirred micr...

Fluid Storage and Shipping Bags

Sartorius Stedim Biotech

Designed for storage and shipping of biopharmaceutical fluids, the new Flexsafe ® 3D Pre-designed Solutions (PDS) meet all the functional and validation requirements of the biopharmaceutical industry. The three-dimensional single-use bag...

  • Page 1 of 1 (5 items) 1 

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »